Alterations in the concentration of serotonergic and dopaminergic substances in the cerebrospinal fluid of patients with Parkinson's disease, and their changes after L-dopa administration

Neurosci Lett. 1993 Sep 3;159(1-2):135-8. doi: 10.1016/0304-3940(93)90817-5.

Abstract

In untreated patients with Parkinson's disease (PD), the total (free and conjugated) serotonin (5-HT) and dopamine (DA) concentrations in the cerebrospinal fluid decreased significantly. While the 5-HT concentration displayed a non-significant trend of negative correlation with the DA concentration in controls, it had a significant positive correlation with the DA concentration in untreated PD patients. In L-dopa-treated patients, the DA concentration increased remarkably, whereas the 5-HT concentration decreased further compared with untreated patients. The tryptophan, 5-hydroxyindolacetic acid (5-HIAA), and 3-OH kynurenine concentrations had significant positive correlations with L-dopa doses. The 5-HT concentration had a significant positive correlation with scores of psychomatric testing in L-dopa-treated patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Dopamine / cerebrospinal fluid*
  • Dopamine / physiology
  • Humans
  • Hydroxyindoleacetic Acid / cerebrospinal fluid
  • Kynurenine / analogs & derivatives
  • Kynurenine / cerebrospinal fluid
  • Levodopa / therapeutic use*
  • Middle Aged
  • Parkinson Disease / cerebrospinal fluid*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / psychology
  • Psychometrics
  • Serotonin / cerebrospinal fluid*
  • Serotonin / physiology

Substances

  • 3-hydroxykynurenine
  • Serotonin
  • Kynurenine
  • Levodopa
  • Hydroxyindoleacetic Acid
  • Dopamine